Table 1

Main characteristics of the 242 patients with noninfectious mixed CryoVas included in the survey, according to the type of MC

CharacteristicsAll patients (n = 242)Type II CryoVas (n = 203)Type III CryoVas (n = 27)P
Epidemiologic features     
    Age at diagnosis, y, mean ± SD 62.6 ± 14.5 63.2 ± 14.5 60.4 ± 14.9 .36 
    Female sex, n (%) 163 (69) 136 (69) 20 (74) .66 
Causes, n (%)    .36 
    Essential MC 117 (48) 95 (47) 15 (56)  
    Connective tissue disease 73 (30) 61 (30) 9 (33)  
    Hematologic disease 52 (22) 47 (23) 3 (11)  
Clinical manifestations, n (%)     
    Skin 201 (83) 172 (85) 19 (70) .10 
    Purpura 182 (75) 158 (78) 15 (56) .02 
    Acrocyanosis 64 (26) 52 (26) 9 (33) .49 
    Ulcers 39 (16) 32 (16) 6 (22) .41 
    Necrosis 35 (14) 28 (14) 5 (19) .56 
    Peripheral nerve 125 (52) 114 (56) 6 (22) .001 
    Sensory 50 (21) 46 (23) 1 (3) .02 
    Sensorimotor 75 (31) 68 (33) 5 (19) .13 
    Joints 97 (40) 84 (41) 8 (30) .30 
    Arthralgias 72 (30) 61 (30) 7 (27) .82 
    Arthritis 25 (10) 23 (11) 1 (3) .32 
    Kidney 84 (35) 77 (38) 4 (15) .02 
    Gastrointestinal tract 13 (5) 12 (6) 0 (0) .37 
    CNS 5 (2) 3 (1) 2 (7) .11 
    Pulmonary 5 (2) 4 (2) 1 (3) .47 
Biologic features     
    Cryoglobulin level, g/L, mean ± SD 0.94 ± 1.61 1.01 ± 1.69 0.42 ± 0.54 .05 
    C3 level, g/L (0.80-1.40), mean ± SD 0.86 ± 0.31 0.83 ± 0.31 1.07 ± 0.33 .009 
    C4 level, g/L (0.14-0.40), mean ± SD 0.07 ± 0.09 0.06 ± 0.07 0.16 ± 0.11 < .0001 
    Creatinine level, μmol/L (55-105), mean ± SD 113 ± 90 112 ± 77 115 ± 136 .86 
    GFR, mL/min, mean ± SD* 69 ± 31 67 ± 30 78 ± 31 .03 
    GFR < 60 mL/min, n (%)* 93 (38) 86 (42) 5 (19) .02 
Outcome     
    Follow-up, mo, mean ± SD 51 ± 54 52 ± 52 40 ± 46 .28 
    Serious infections, n (%) 54 (22) 51 (25) 2 (7) .05 
    Death, n (%) 42 (17) 40 (20) 1 (4) .06 
CharacteristicsAll patients (n = 242)Type II CryoVas (n = 203)Type III CryoVas (n = 27)P
Epidemiologic features     
    Age at diagnosis, y, mean ± SD 62.6 ± 14.5 63.2 ± 14.5 60.4 ± 14.9 .36 
    Female sex, n (%) 163 (69) 136 (69) 20 (74) .66 
Causes, n (%)    .36 
    Essential MC 117 (48) 95 (47) 15 (56)  
    Connective tissue disease 73 (30) 61 (30) 9 (33)  
    Hematologic disease 52 (22) 47 (23) 3 (11)  
Clinical manifestations, n (%)     
    Skin 201 (83) 172 (85) 19 (70) .10 
    Purpura 182 (75) 158 (78) 15 (56) .02 
    Acrocyanosis 64 (26) 52 (26) 9 (33) .49 
    Ulcers 39 (16) 32 (16) 6 (22) .41 
    Necrosis 35 (14) 28 (14) 5 (19) .56 
    Peripheral nerve 125 (52) 114 (56) 6 (22) .001 
    Sensory 50 (21) 46 (23) 1 (3) .02 
    Sensorimotor 75 (31) 68 (33) 5 (19) .13 
    Joints 97 (40) 84 (41) 8 (30) .30 
    Arthralgias 72 (30) 61 (30) 7 (27) .82 
    Arthritis 25 (10) 23 (11) 1 (3) .32 
    Kidney 84 (35) 77 (38) 4 (15) .02 
    Gastrointestinal tract 13 (5) 12 (6) 0 (0) .37 
    CNS 5 (2) 3 (1) 2 (7) .11 
    Pulmonary 5 (2) 4 (2) 1 (3) .47 
Biologic features     
    Cryoglobulin level, g/L, mean ± SD 0.94 ± 1.61 1.01 ± 1.69 0.42 ± 0.54 .05 
    C3 level, g/L (0.80-1.40), mean ± SD 0.86 ± 0.31 0.83 ± 0.31 1.07 ± 0.33 .009 
    C4 level, g/L (0.14-0.40), mean ± SD 0.07 ± 0.09 0.06 ± 0.07 0.16 ± 0.11 < .0001 
    Creatinine level, μmol/L (55-105), mean ± SD 113 ± 90 112 ± 77 115 ± 136 .86 
    GFR, mL/min, mean ± SD* 69 ± 31 67 ± 30 78 ± 31 .03 
    GFR < 60 mL/min, n (%)* 93 (38) 86 (42) 5 (19) .02 
Outcome     
    Follow-up, mo, mean ± SD 51 ± 54 52 ± 52 40 ± 46 .28 
    Serious infections, n (%) 54 (22) 51 (25) 2 (7) .05 
    Death, n (%) 42 (17) 40 (20) 1 (4) .06 

For 12 patients, cryoglobulinemia was not typed. Normal values are indicated for C3, C4, and creatinine levels between parentheses. Type II is MC with a monoclonal component. Type III is MC with only polyclonal immunoglobulins.

*

GFR was assessed with the Modified Diet in Renal Disease equation.

Close Modal

or Create an Account

Close Modal
Close Modal